Tanaka, Y.; Miki, D.; Hayes, C.N.; Kawahara, M.; Sueda, S.; Emori, T.; Hashimoto, K.; Mitamura, Y.; Tanaka, A.; Hiraoka, K.;
et al. A Study on the Association Between Treatment Response to Atezolizumab Plus Bevacizumab Combination Therapy for Advanced Hepatocellular Carcinoma and Gut Microbiota. Microorganisms 2026, 14, 867.
https://doi.org/10.3390/microorganisms14040867
AMA Style
Tanaka Y, Miki D, Hayes CN, Kawahara M, Sueda S, Emori T, Hashimoto K, Mitamura Y, Tanaka A, Hiraoka K,
et al. A Study on the Association Between Treatment Response to Atezolizumab Plus Bevacizumab Combination Therapy for Advanced Hepatocellular Carcinoma and Gut Microbiota. Microorganisms. 2026; 14(4):867.
https://doi.org/10.3390/microorganisms14040867
Chicago/Turabian Style
Tanaka, Yusuke, Daiki Miki, C. Nelson Hayes, Michihiko Kawahara, Saki Sueda, Tomoaki Emori, Kou Hashimoto, Yuri Mitamura, Aiko Tanaka, Keiichi Hiraoka,
and et al. 2026. "A Study on the Association Between Treatment Response to Atezolizumab Plus Bevacizumab Combination Therapy for Advanced Hepatocellular Carcinoma and Gut Microbiota" Microorganisms 14, no. 4: 867.
https://doi.org/10.3390/microorganisms14040867
APA Style
Tanaka, Y., Miki, D., Hayes, C. N., Kawahara, M., Sueda, S., Emori, T., Hashimoto, K., Mitamura, Y., Tanaka, A., Hiraoka, K., Johira, Y., Miura, R., Fujino, H., Ono, A., Murakami, E., Kawaoka, T., Tsuge, M., & Oka, S.
(2026). A Study on the Association Between Treatment Response to Atezolizumab Plus Bevacizumab Combination Therapy for Advanced Hepatocellular Carcinoma and Gut Microbiota. Microorganisms, 14(4), 867.
https://doi.org/10.3390/microorganisms14040867
